View in EDS HTML Full Text PDF Full Text

Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab.

Saved in:
Bibliographic Details
Title: Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab.
Authors: Smits F; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.; Department of Hematology, Haga Hospital, The Hague, the Netherlands., Groen K; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Korst CLBM; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Frerichs KA; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Kuipers I; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Kruyswijk S; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., de Ruijter MEM; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Zweegman S; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., van de Donk NWCJ; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands. n.vandedonk@amsterdamumc.nl.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands. n.vandedonk@amsterdamumc.nl.
Source: Blood cancer journal [Blood Cancer J] 2026 Feb 21; Vol. 16 (1). Date of Electronic Publication: 2026 Feb 21.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41720763
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Smits+F%22">Smits F</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.; Department of Hematology, Haga Hospital, The Hague, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Groen+K%22">Groen K</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Korst+CLBM%22">Korst CLBM</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Frerichs+KA%22">Frerichs KA</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuipers+I%22">Kuipers I</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kruyswijk+S%22">Kruyswijk S</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Ruijter+MEM%22">de Ruijter MEM</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Nasserinejad+K%22">Nasserinejad K</searchLink>; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zweegman+S%22">Zweegman S</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Donk+NWCJ%22">van de Donk NWCJ</searchLink>; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands. n.vandedonk@amsterdamumc.nl.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands. n.vandedonk@amsterdamumc.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2026 Feb 21; Vol. 16 (1). <i>Date of Electronic Publication: </i>2026 Feb 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41720763
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-026-01451-9
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Smits F
      – PersonEntity:
          Name:
            NameFull: Groen K
      – PersonEntity:
          Name:
            NameFull: Korst CLBM
      – PersonEntity:
          Name:
            NameFull: Frerichs KA
      – PersonEntity:
          Name:
            NameFull: Kuipers I
      – PersonEntity:
          Name:
            NameFull: Kruyswijk S
      – PersonEntity:
          Name:
            NameFull: de Ruijter MEM
      – PersonEntity:
          Name:
            NameFull: Nasserinejad K
      – PersonEntity:
          Name:
            NameFull: Zweegman S
      – PersonEntity:
          Name:
            NameFull: van de Donk NWCJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 02
              Text: 2026 Feb 21
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1